Comparison of stimulated versus modified natural cycles for endometrial preparation prior to frozen embryo transfer: a randomized controlled trial.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 03 08 2019
revised: 08 12 2019
accepted: 13 01 2020
pubmed: 18 3 2020
medline: 7 4 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

To compare stimulated cycle (STC) versus modified natural cycle (MNC) for endometrial preparation prior to frozen embryo transfer (FET) in terms of convenience and efficacy. Prospective, open-label, randomized controlled study including 119 patients aged 20-38 years, undergoing intra-conjugal IVF/intracytoplasmic sperm injection, having regular cycles, at least two day 2 or day 3 frozen embryos, for whom it was the first or second FET performed, randomized to either MNC (n = 59) or STC (n = 60). Monitoring consisted of ultrasound and hormonal measurements. The number of monitoring visits required was compared between the two groups. STC required a significantly lower number of monitoring visits compared with MNC (3.6 ± 0.9 versus 4.4 ± 1.1, respectively, P < 0.0001), a lower number of blood tests (2.7 ± 0.8 versus 3.5 ± 1.0, respectively, P < 0.0001) and of ultrasounds (1.2 ± 0.4 versus 1.5 ± 0.6, respectively, P = 0.0039). FET during 'non-opening' hours (22.6% versus 27.5%, respectively, P = 0.32) and cancellation rates (11.7% versus 11.9%, respectively, P = 0.97) were comparable between the STC and MNC groups. No difference concerning HCG-positive rates (34.0% versus 23.1%, respectively, P = 0.22) nor live birth rates (24.5% for STC versus 23.1% for MNC, respectively, P = 0.86) was observed. Quality of life as defined by the FertiQol score was not different (P > 0.05 for each item). Altogether, these findings can be used for everyday clinical practice to better inform patients when deciding on the protocol to use for FET. These results suggest that MNC is a good option for patients reluctant to have injections, but requires increased monitoring. STC may offer more flexibility for patients and IVF centres.

Identifiants

pubmed: 32179010
pii: S1472-6483(20)30025-0
doi: 10.1016/j.rbmo.2020.01.007
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

518-524

Informations de copyright

Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Julie Labrosse (J)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Annina Lobersztajn (A)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France; Department of Gynecology, Obstetrics and Reproductive Medicine, Hôpital Pierre Rouquès Les Bluets, Paris, France.

Claire Pietin-Vialle (C)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Claire Villette (C)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Anne Lucie Dessapt (AL)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France; IVI Clinic Barcelona Barcelona, Spain.

Camille Jung (C)

Clinical Research Centre, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Maxime Brussieux (M)

Clinical Research Centre, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Helene Bry-Gauillard (H)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Maud Pasquier (M)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France.

Nathalie Massin (N)

Department of Gynecology, Obstetrics and Reproductive Medicine, Centre Hospitalier Intercommunal de Créteil, Université Paris-Est Créteil, Créteil, France. Electronic address: nathalie.massin@chicreteil.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH